2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1124361076 MD
Verify on CMS →

Matthew Adams, MD

Retina Specialist (Ophthalmology) Physician in Plano, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 913 in Retina Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
407
Medicare Part D claims · 125 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$15.1K
38 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Matthew Adams, MD filed 407 Medicare Part D claims in 2023 as a Retina Specialist (Ophthalmology) Physician in Plano, Texas, prescribing 61% generic.

407
Part D claims, 2023
61%
generic prescribing
$15.1K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Matthew Adams, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

407 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Matthew Adams, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Matthew Adams, MD?

Quality data not reported

NPI registry status

Active

Issued 03/28/2013

NPI 1124361076

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

407 27% vs specialty avg

2023 prescription claims

Specialty avg: 558

Specialty distribution in Texas

How Retina Specialist (Ophthalmology) Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Retina Specialist (Ophthalmology) Physician - 0%Retina Specialist (Ophthalmology) Physician0%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Retina Specialist (Ophthalmology) Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Matthew Adams, MD appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD credentials at 6843 COMMUNICATIONS PKWY STE 810, Plano, TX, 75024, with a listed phone of (972) 440-2020. NPI 1124361076 was issued on 03/28/2013.

Medicare Part D records for calendar year 2023 show 407 prescription claims written by this provider, covering 125 Medicare beneficiaries and totaling roughly $38K in drug spend, split 39% brand-name and 61% generic by claim count.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6843 COMMUNICATIONS PKWY STE 810
Plano, TX 75024

Provider Details

NPI 1124361076
Specialty Retina Specialist (Ophthalmology) Physician
Credentials MD
Gender Male
NPI Issued 03/28/2013

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Adams, MD. Source: openpaymentsdata.cms.gov.

Total received

$15.1K

Largest payer

Alimera Sciences, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Matthew Adams, MD. To verify Matthew Adams, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Matthew Adams, MD - brand share 39.0%
Retina Specialist (Ophthalmology) Physician average

39% brand-name claims vs 61% generic, on 407 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

407
Total Claims
$38K
Total Drug Cost
125
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
661
Total Day Supply
18,599
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$29K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
75.4 years
Avg HCC Risk Score
1.46
Gender Split
55% female / 45% male
Age Distribution
<65: 11, 65-74: 49, 75-84: 43, 85+: 22

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Matthew Adams, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
94
Prednisolone Acetate
62
Timolol Maleate
35
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
34
Brimonidine Tartrate
29
Ketorolac Tromethamine
19
Erythromycin
Erythromycin Base
17
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How Matthew Adams, MD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

Matthew Adams, MD's 407 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Adams.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Retina Specialist (Ophthalmology) Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Matthew Adams, MD's specialty?
Matthew Adams, MD specializes in Retina Specialist (Ophthalmology) Physician and practices in Plano, Texas. Credentials: MD.
How much does Matthew Adams, MD prescribe under Medicare Part D?
In 2023, Matthew Adams, MD wrote 407 Medicare Part D claims totaling $38K in drug costs for 125 beneficiaries.
Where is Matthew Adams, MD located?
Matthew Adams, MD is located at 6843 COMMUNICATIONS PKWY STE 810, Plano, TX, 75024. Phone: (972) 440-2020.
What is Matthew Adams, MD's NPI number?
Matthew Adams, MD's National Provider Identifier (NPI) is 1124361076, issued on 03/28/2013.
Does Matthew Adams, MD prescribe more brand-name or generic drugs?
Matthew Adams, MD's prescribing is 39% brand-name and 61% generic drugs by claim count, with $29K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does Matthew Adams, MD prescribe most often?
Based on 2023 Medicare Part D data, Matthew Adams, MD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Adams, MD accept Medicare?
Matthew Adams, MD appears in CMS Medicare data with 407 Part D claims and 125 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Adams, MD's credentials?
Matthew Adams, MD's NPI is 1124361076 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.